Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect

Annals of Intensive Care

Table 2 Microbial documentation of infectious events in ICU patients with severe COVID-19

Microbiological documentation	Community-acquired infections	Early hospital-acquired infections	Late hospital-acquired infections
Bacterial pneumonia
Acinetobacter baumannii, n (%)	0 (0)	1 (3)	0 (0)
Citrobacter koseri, n (%)	0 (0)	1 (3)	1 (3)
Escherichia coli, n (%)	0 (0)	0 (0)	1 (3)
Haemophilus influenzae, n (%)	1 (3)	4 (11)	0 (0)
Klebsiella sp., n (%)	1 (3)	3 (8)	1 (3)
Moraxella catarrhalis, n (%)	0 (0)	1 (3)	0 (0)
Morganella morganii, n (%)	0 (0)	0 (0)	1 (3)
Pseudomonas aeruginosa, n (%)	1 (3)	2 (6)	5 (14)
Serratia sp., n (%)	1 (3)	0 (0)	1 (3)
Staphylococcus aureus, n (%)	1 (3)	2 (6)	4 (11)
Stenotrophomonas maltophila, n (%)	1 (3)	0 (0)	1 (3)
Streptococcus constellatus, n (%)	0 (0)	0 (0)	1 (3)
Bacteremia
Corynebacterium sp., n (%)	1 (3)	0 (0)	0 (0)
Enterococcus faecalis, n (%)	0 (0)	0 (0)	1 (3)
Klebsiella pneumoniae, n (%)	0 (0)	0 (0)	1 (3)
Pseudomonas aeruginosa, n (%)	0 (0)	0 (0)	1 (3)
Streptococcus mitis, n (%)	0 (0)	0 (0)	1 (3)
Fungal pneumonia^a
Aspergillus fumigatus, n (%)	1 (3)	0 (0)	2 (6)
Fungemia^a
Candida albicans, n (%)	0 (0)	0 (0)	2 (6)

^aAll fungal events are reported in the table, while only first bacterial events are given in the table